A previous study found that CD163/FKBP51s cells in the PB increased following incomplete tumor resection (15), suggesting that tumor persistence associated with disruption of the blood-brain barrier promotes the release of these TAMs into circulation. This evidence concerns the gene CD163 and neoplasm.